乳房病变定位方法市场[按类型（线定位活检，放射性同位素定位（放射性导致神经病变定位，放射性种子定位），磁性示踪剂等）;and by Regions (North America - U.S., Canada; Europe - Germany, UK, France, Italy, Russia; Asia-Pacific - China, India, Japan, Australia; Latin America - Brazil, Mexico; Middle East & Africa)]: Market size & Forecast, 2018 – 2026

报告摘要

2017年全球乳房病变定位方法的市场规模估计为570.35亿美元，并预计未来几年将获得大量牵引力。

乳腺癌是一种由不受控制和未经组织的乳腺细胞增殖分类的疾病，其形成肿瘤，其本质上可能是非恶性或恶性的。由于疾病或损害而导致乳房组织的不规则变化称为乳腺病变。恶性病变是癌症，而良性病变是非癌的。乳房肿块是所有年龄段的女性之间的普遍抱怨。这种细胞通常形成通常在X射线上观察或感觉块时可以观察到的肿瘤。乳房肿块会导致乳房和乳房疼痛的变化也可能发生。乳腺癌最常见的是40岁及以上的女性，与其相同的百分比百分比相同。目前一种小型无线血损伤定位方法目前用于鉴定不可触及的可疑乳腺病变，这是可能获得主要牵引力的现代程序之一，并反过来增强全球乳房病变定位方法市场的增长在预测期间。乳房筛选阵容很偏好对乳腺癌的早期识别，这进一步支持其具有新技术的适当治疗方法。 According to Department of Oncology 2007, approximately 25% of the cancers were non-palpable that required precise treatment including radio-guided occult lesion localization.

The global market growth for breast lesion localization methods is driven by factors such as rising global occurrence of people suffering breast cancer and favorable reimbursement policies in developed economies. According to the World Health Organization (WHO), in 2012, breast cancer was the second-most prevalent cancer in the world and most frequent cancer among women, with an estimated around 1.7 Million new cancer cases diagnosed in that year. Moreover, according to the statistics of the Breastcancer.org 2017, in the U.S. approximately 250,000 cases of invasive breast cancer are expected to be diagnosed along with over 60,000 cases of non-invasive breast cancer. This, in turn, generates a significant environment for global breast lesion localization methods market during the forecast period. In addition, advancement in technology including electromagnetic and magnetic tracer owing to technological advancement also driving the growth of this market. The control on traditional localization methods recognized by the physician has also augmented the demand for breast lesion localization methods market. Furthermore, growing awareness of amongst the people regarding the breast cancer and increasing in improved quality treatment is another factor bolster the demand for this market.

然而,歧义在产品FDA的批准,risk associated with the breast surgery and painful consequences are factors anticipated to hinder the growth of this market.

Segment Analysis

全球乳房病变定位方法在类型和地理的基础上进行市场规模。

在类型的基础上，全球市场被分段为电线定位活检，放射性同位素定位磁性示踪剂等。放射性同位素定位区段进一步分为放射引导神秘的病变定位和放射性种子定位。电线定位，也称为针定位或线引导活检，由于其早期改善和最终用户等最终用户，如医院和肿瘤学治疗中心，因此占据市场。由于其Imprsoved患者以治愈癌症的新机制效率，预计磁性示踪剂预计将成为预测期内的最快增长段。例如，仪器，燕尾探针和磁性示踪剂，Sienna +的组合有助于形成精确和无毒的方法。此外，经济，优质的外科设计和改进的工作流程管理支持这一细分市场的发展。

Regional Analysis

In terms of geography, North America is estimated to be the highest market sharing region in 2017. Availability of key manufacturers in the U.S, improved healthcare structure, and high adoption rate of these localization methods are some of the factors accountable for its largest share in breast session location methods market. Moreover, favorable government support and an increasing number of breast cancer treatment surgeries being performed are some of the drivers anticipated to fuel the profitable market growth in this region. However, Asia Pacific is estimated to be the dominating region during the upcoming decade. The major market share is highly due to the increasing per head income, high unmet medical needs of appropriate patient care, increasing awareness regarding early cancer diagnosis, and accessibility of operative cure in emerging economies, such as India and China.

Competitive Landscape

Major firms are focusing on small firms with a working methodology of securing the end goal to manage position in the market and are associated with mergers and acquisitions, key joint efforts, and novel item advancement to pick up profit share in the business. Some major key players in global Breast Lesion Localization Methods Market includes Cianna Medical, Cook Medical, STERYLAB, CP Medical, Inc., SOMATEX Medical Technologies GmbH, Argon Medical Devices, Inc., and C.R. BARD, Inc. among others.